Cargando…
Extensive phenotypic characterisation of a human TDP-43(Q331K) transgenic mouse model of amyotrophic lateral sclerosis (ALS)
The majority of preclinical studies in ALS have relied on transgenic models with overexpression of mutant human superoxide dismutase 1 (SOD1), widely regarded to have failed in terms of translation of therapeutic effects. However, there are still no widely accepted models of other genetic subtypes o...
Autores principales: | Watkins, Jodie A., Alix, James J. P., Shaw, Pamela J., Mead, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370970/ https://www.ncbi.nlm.nih.gov/pubmed/34404845 http://dx.doi.org/10.1038/s41598-021-96122-z |
Ejemplares similares
-
Female sex mitigates motor and behavioural phenotypes in TDP-43(Q331K) knock-in mice
por: Watkins, Jodie, et al.
Publicado: (2020) -
Author Correction: Female sex mitigates motor and behavioural phenotypes in TDP-43(Q331K) knock-in mice
por: Watkins, Jodie, et al.
Publicado: (2021) -
Complement components are upregulated and correlate with disease progression in the TDP-43(Q331K) mouse model of amyotrophic lateral sclerosis
por: Lee, John D., et al.
Publicado: (2018) -
The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1(G93A) and TDP-43(Q331K) transgenic mouse models of ALS
por: Keerie, Amy, et al.
Publicado: (2021) -
TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014)